ArticleCell division2025

Maraviroc enhances Bortezomib sensitivity in multiple myeloma by inhibiting M2 macrophage polarization via PI3K/AKT/RhoA signaling pathway in macrophages.

Huiye Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.